Form 8-K - Current report:
SEC Accession No. 0001962918-25-000003
Filing Date
2025-01-06
Accepted
2025-01-06 16:01:46
Documents
13
Period of Report
2025-01-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20250106.htm   iXBRL 8-K 31998
  Complete submission text file 0001962918-25-000003.txt   160433

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20250106.xsd EX-101.SCH 1773
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20250106_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20250106_pre.xml EX-101.PRE 13037
15 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20250106_htm.xml XML 2815
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25510982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)